Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|October 14, 2022
TCR <i>CDR3</i> Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune ThrombocytopeniaLili Ji, Yanxia Zhan, Boting Wu, et al.
Journal of Translational Medicine|March 4, 2018
Distinct alterations of CD68<sup>+</sup>CD163<sup>+</sup> M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatmentXia Shao, Boting Wu, Luya Cheng, et al.
Journal of Clinical Immunology|June 7, 2012
Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopeniaFanli Hua, Lili Ji, Yanxia Zhan, et al.
The New England Journal of Medicine|August 29, 2003
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasoneYunfeng Cheng, Raymond S M Wong, Yannie O Y Soo, et al.
Immunologic Research|January 1, 2015
Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patientsFeng Li, Lili Ji, Weiguang Wang, et al.
Annals of Hematology|June 3, 2019
The abnormal function of CD39<sup>+</sup> regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopeniaYumeng Lu, Luya Cheng, Feng Li, et al.
Future Oncology (London, England)|February 5, 2019
The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinomaBeili Wang, Feng Li, Luya Cheng, et al.
Biosensors & Bioelectronics|November 16, 2020
An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injuryFangqin Wang, Xuefeng Jiang, Huaijiang Xiang, et al.
Clinical & Translational Immunology|July 5, 2022
Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interactionPengcheng Xu, Xia Shao, Yang Ou, et al.
Experimental Hematology & Oncology|September 1, 2022
Impaired mitochondria of Tregs decreases OXPHOS-derived ATP in primary immune thrombocytopenia with positive plasma pathogens detected by metagenomic sequencingYanxia Zhan, Jingjing Cao, Lili Ji, et al.
Pageof 12